Jump to content

Orticumab

From Wikipedia, the free encyclopedia
Orticumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetoxLDL
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII

Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.[1]

References

[edit]
  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).